Kay, J., Fleischmann, R., Keystone, E., Hsia, E. C., Hsu, B., Mack, M., . . . Kavanaugh, A. (2015). Golimumab 3-year safety update: An analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Ann Rheum Dis.
Chicago-stil citatKay, Jonathan, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Michael Mack, Neil Goldstein, Jürgen Braun, och Arthur Kavanaugh. "Golimumab 3-year Safety Update: An Analysis of Pooled Data From the Long-term Extensions of Randomised, Double-blind, Placebo-controlled Trials Conducted in Patients With Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis." Ann Rheum Dis 2015.
MLA-referensKay, Jonathan, et al. "Golimumab 3-year Safety Update: An Analysis of Pooled Data From the Long-term Extensions of Randomised, Double-blind, Placebo-controlled Trials Conducted in Patients With Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis." Ann Rheum Dis 2015.